CARL
CARL
NASDAQ · Health Care

Carlsmed Inc

$9.44
-0.19 (-1.97%)
Financial Highlights (FY 2025)
Revenue
199.13M
Net Income
14.97M
Gross Margin
65.9%
Profit Margin
7.5%
Rev Growth
+10.8%
D/E Ratio
0.67
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 65.9% 65.9% 65.9%
Operating Margin 10.3% 10.3% 9.2%
Profit Margin 7.5% 7.8% 6.4%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 199.13M 178.35M 186.57M
Gross Profit 131.23M 117.54M 122.96M
Operating Income 20.60M 18.29M 17.09M
Net Income 14.97M 13.87M 11.95M
Gross Margin 65.9% 65.9% 65.9%
Operating Margin 10.3% 10.3% 9.2%
Profit Margin 7.5% 7.8% 6.4%
Rev Growth +10.8% -6.6% +4.6%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 105.85M 104.96M 106.36M
Total Equity 158.44M 173.12M 151.72M
D/E Ratio 0.67 0.61 0.70
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 27.78M 26.96M 24.29M
Free Cash Flow 11.84M 12.39M 10.96M